Table 4.
Comparison between combined MOG antibody-positive and -negative children with anti-NMDAR encephalitis.
| MOG-positive | MOG-negative | X2 or t-value | P-value | |
|---|---|---|---|---|
| Total | 15 | 74 | ||
| Age (mean ± SE, year) | 6.31 ± 3.82 | 7.60 ± 3.92 | −1.162 | 0.248 |
| Preceding infection | 8 (53.3%) | 18 (24.3%) | 5.075 | 0.024 |
| Status epilepticus | 5 (33.3%) | 26 (35.1%) | 1.103 | 0.218 |
| Consciousness disturbance | 6 (40.0%) | 23 (31.1%) | 0.452 | 0.502 |
| CSF pleocytosis (≧5/mm3) | 7 (46.7%) | 34 (43.2%) | 0.002 | 0.964 |
| Anti-NMDAR antibody titer ≧100 | 7 (46.7%) | 33 (44.6%) | 0.003 | 0.959 |
| CSF Oligoclonal band | 9 (60.0%) | 43 (58.1%) | 0.018 | 0.892 |
| Cranial MRI with abnormal white matter | 4 (26.7%) | 14 (18.9%) | 0.464 | 0.496 |
| Extreme delta brush | 1 (6.7%) | 14 (18.9%) | 1.336 | 0.248 |
| ICU admission | 1 (6.7%) | 6 (8.1%) | 0.036 | 0.850 |
| Relapse | 5 (33.3%) | 7 (9.5%) | 6.094 | 0.014 |
| Second-line immunology | 6 (40.0%) | 26 (35.1%) | 0.066 | 0.797 |
| Sequela | 2 (13.3%) | 12 (16.2%) | 0.078 | 0.780 |